Last Updated on December 12, 2019 by Team Spinfuel
Researchers have found that in states with legal cannabis, or Pot, people are skipping over the counter sleep aids in favor of said pot. Well, yea. I mean, come on, over the counter sleep aids are useless. I should know, I’ve been using Ambien for years and years, after trying OTC Sleep Aids without ever feeling sleepy. Of course smoking a bit of pot is going to make you sleepy, it’s one of the natural effects of THC.
However, for many people, it depends on the strain and how much is consumed.
BlogTown in Portland
There’s a reason sleep deprivation is used as a form of torture, because after just a few nights of enduring it, many will gladly give up state secrets. About 70 million people in the United States struggle with sleep disorders, the most common being insomnia. I am one of them.
That said, a new study published in the December edition of Complementary Therapies in Medicine shows that when consumers are given the option of obtaining cannabis through a recreational use program, they will increasingly use cannabis in place of over the counter (OTC) sleep aid medications.
“A host of studies and reports has linked insufficient sleep to depression, ADHD, obesity, Type 2 diabetes, cardiovascular disease, cancer, and Alzheimer’s. Back in 2014, the CDC labeled sleep deprivation a public health epidemic—with over 70 million adults suffering from a sleep disorder. Sleeplessness is also connected to other severe consequences: The National Highway Traffic Safety Administration estimates that drowsy driving causes 1,550 deaths and 40,000 injuries annually in the United States.”
They determined that prior to the opening of a dispensary in a county, the sale of OTC sleep aids was consistent. After the dispensary opened, those sales began declining after the first month, even more following the second month, and so on. Weep for the pharmaceutical industry, because as Marijuana Moment writes, “A regression model showed that sleep aid market share growth decreased by 236 percent after a dispensary entered the market, and this negative association increased as the number of dispensaries grew.”
The study noted that cannabis “competed favorably” with products containing “diphenhydramine and doxylamine, which constitute 87.4% of the market for OTC sleep aids.”
Other studies have shown how providing access to cannabis through a regulated program results in reduced opioid prescriptions, reduced opioid use, and as one study showed “opioid mortality rates drop when recreational marijuana becomes widely available via dispensaries.”
